Breast Cancer Patient Demographic Data
| Randomized Patients N = 89 . | Arm A (CD34+) . | Arm B (Buffy Coat) . | P . |
|---|---|---|---|
| . | (n = 42) . | (n = 47) . | . |
| Age (yr) | |||
| Mean | 44 | 42 | .119 |
| Range | (32-58) | (30-55) | |
| Weight (kg) | |||
| Mean | 67 | 70 | .379 |
| Range | (34-97) | (50-122) | |
| Stage II/III | 17 (40%) | 17 (36%) | .710 |
| Stage IV | 25 (60%) | 30 (64%) | .827 |
| ER status | .380 | ||
| Positive (%) | 19 (45%) | 27 (57%) | |
| Negative (%) | 16 (38%) | 16 (34%) | |
| Unknown (%) | 7 (17%) | 4 (9%) | |
| Yr from initial diagnosis to BMT | 2.6 (0.2-16.7) | 2.1 (0.1-7.8) | .470 |
| No. of previous chemotherapy regimens | .751 | ||
| 1 | 23 (55%) | 28 (60%) | |
| 2 | 18 (43%) | 17 (36%) | |
| 3 | 1 (2%) | 2 (4%) | |
| No. previous chemotherapy cycles | 8 (3-18) | 7 (2-13) | .246 |
| No. patients who received prior RT | 9 (21%) | 11 (23%) | 1.00 |
| Randomized Patients N = 89 . | Arm A (CD34+) . | Arm B (Buffy Coat) . | P . |
|---|---|---|---|
| . | (n = 42) . | (n = 47) . | . |
| Age (yr) | |||
| Mean | 44 | 42 | .119 |
| Range | (32-58) | (30-55) | |
| Weight (kg) | |||
| Mean | 67 | 70 | .379 |
| Range | (34-97) | (50-122) | |
| Stage II/III | 17 (40%) | 17 (36%) | .710 |
| Stage IV | 25 (60%) | 30 (64%) | .827 |
| ER status | .380 | ||
| Positive (%) | 19 (45%) | 27 (57%) | |
| Negative (%) | 16 (38%) | 16 (34%) | |
| Unknown (%) | 7 (17%) | 4 (9%) | |
| Yr from initial diagnosis to BMT | 2.6 (0.2-16.7) | 2.1 (0.1-7.8) | .470 |
| No. of previous chemotherapy regimens | .751 | ||
| 1 | 23 (55%) | 28 (60%) | |
| 2 | 18 (43%) | 17 (36%) | |
| 3 | 1 (2%) | 2 (4%) | |
| No. previous chemotherapy cycles | 8 (3-18) | 7 (2-13) | .246 |
| No. patients who received prior RT | 9 (21%) | 11 (23%) | 1.00 |
Abbreviations: ER, estrogen receptor; BMT, bone marrow transplant; RT, radiation therapy.